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A B S T R A C T
A 61-year-old female presented with eosinophilic pneumonia accompanied by bronchial asthma. She
was ﬁnally diagnosed with allergic bronchopulmonary mycosis (ABPM) due to co-infection with
Aspergillus fumigatus and Schizophyllum commune detected by genetic analysis of the plug and from
cultures.
 2014 The Authors. Published by Elsevier Ltd. 
Contents lists available at ScienceDirect
IDCases
jo u rn al ho m epag e: ww w.els evier . c om / lo cat e/ idc r
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A 61-year-old female who had never smoked was referred to
Osaka University Hospital with a productive cough, shortness of
breath, and wheezing for 5 years. She had a high eosinophil range
of 6–20% (normal, 2–4%) and transient recurrent inﬁltrates on
serial chest X-rays. Eosinophilic pneumonia with bronchial asthma
had been diagnosed and treatment with oral prednisolone resulted
in the remission of symptoms for 2–3 weeks at a time.
The patient complained of up to 10 mL of sputum per day which
was purulent, malodorous and sometimes formed mucoid plugs.
She was prescribed with inhaled corticosteroids and long-acting
beta-agonists. She was found to have bilateral coarse crepitations
with biphasic polyphonic rhonchi on pulmonary examination.* Corresponding author at: Division of Infection Control and Prevention, Osaka
University Hospital, 2-15 Yamadaoka, Suita City, Osaka 565-0871, Japan. Tel.: +81 6
6879 5093; fax: +81 6 6879 5094.
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mL; with 44.7% polymorphs, 36.8% lymphocytes, 5.5% monocytes,
11.9% eosinophils, and 1.1% basophils. The absolute eosinophil
count was elevated at 861/mL. Serum biochemistry ﬁndings were
unremarkable, and Aspergillus spp. IgG antibody was negative.
Total IgE was within the normal range (70.36 IU/mL), but speciﬁc
IgE for Aspergillus spp. was found to be positive.
A chest X-ray showed inﬁltrates in the right lower lung (Fig. 1A),
and computed tomography revealed bilateral dilation of the
central bronchi in the right upper lobe (Fig. 1B). The involved
bronchi contained hyperattenuating mucus. Bilateral central
bronchiectasis was diagnosed. The patient was further investigat-
ed because saccular bronchiectasis is a feature of allergic
bronchopulmonary aspergillosis (ABPA). Direct analysis of sputum
samples using random sequencing (shotgun sequence) using a
next-generation sequencer revealed fungal DNA. Aspergillus
fumigatus was dominant and four other fungal sequences including
Schizophyllum commune were found (Table 1).
Microscopic assessment of sputum was negative for acid-fast
bacilli (AFB) and other bacteria. However, Charcot–Leyden crystals
that are generated through the breakdown of eosinophils and
hyphaewereidentiﬁed(Fig.1C and D). Directmicroscopy ofKOH wet
mounts of three consecutive sputum specimens and expectorated
sputum/mucoid plugs revealed two types of septate and branching license.
Fig. 1. Chest images and pathological ﬁndings of mucus plug from the patient. (A) X-ray image shows inﬁltration shadows (arrow) that moved in each period. (B) Computed
tomography image shows proximal bronchiectasis (arrow) and mucus plug (arrowhead). (C) Hematoxylin–eosin staining shows Charcot–Leyden crystals (arrows) with
clusters of eosinophils. (D). Periodic acid–Schiff’s stain shows hyphae (arrowheads) indicating fungal infection.
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inoculatedontoSabouraud’sglucoseagar(SGA)developedgreenand
white colonies with a wooly texture after 4 days at 2 8C (Fig. 2C and
D).
One of the fungi was morphologically identiﬁed as A. fumigatus
(Fig. 2A and C), but the other (Fig. 2B and D) remained obscure.
Therefore, DNA was extracted and the internal transcribed spacer
region (ITS) and the D1/D2 region of large subunit rRNA gene were
ampliﬁed by PCR. Direct sequencing of the PCR products showed
that the sequences of the ITS and D1/D2 regions were 100% similarTable 1










5 Aspergillus fumigatus, Penicillium, Talaromyces
6 Aspergillus fumigatus, Penicillium, Talaromyces,
Chaetomium
7 Unknown Penicillium, Dunaliella
8 Aspergillus fumigatus, Aspergillus terreus
9 Penicillium solitum, Aspergillus oryzae
10 Paecilomyces, Aspergillus fumigatus, Neosartorya
11 Paecilomyces, Aspergillus fumigatus, Neosartorya
12 Paecilomyces, Aspergillus fumigatus, Neosartorya
13 Cryptocercus, Metainae, Hispanognatha,
Antillognata, Allende
14 Penicillium solitum, Aspergillus oryzae
15 Unknown Penicillium, Unknown Aspergillus, Poria
16 Penicillium chrysogenum, Aspergillus niger, Poria cocos,
Aspergillus oryzaeto those of various S. commune strains, such as IFM 46097. The
diagnosis of allergic bronchopulmonary mycosis (ABPM) due to co-
infection with A. fumigatus and S. commune was made.
The susceptibility of the isolated A. fumigatus and S. commune
strains to antifungal drugs (minimum inhibitory concentration;
MIC) was as follows: amphotericin B (1 and 0.5 mg/mL), 5-
ﬂuorocytosine (64 and 0.25 mg/mL), ﬂuconazole (>64 and 4 mg/
mL), itraconazole (0.12 and 0.25 mg/mL), voriconazole (0.5 and
0.12 mg/mL), and micofungin (0.03 and >16 mg/mL), respectively.
The administration of oral itraconazole and prednisolone,
improved the symptoms in this patient.
Discussion
The form of pulmonary hypersensitivity known as allergic
bronchopulmonary mycosis (ABPM) is generally diagnosed using
the criteria by Rosenberg et al. [1]. The most common etiological
agent is A. fumigatus, but other Aspergillus species and fungi can
also be responsible [2–5].
S. commune (‘‘suehirotake’’ in Japanese), is a widely distributed
ﬂeshy fungus that is often found on decaying organic matter,
especially rotting wood. It belongs to the Phylum Basidiomycota,
Subphylum Agaricomycotina, Order Agaricales that contains fungi
that are colloquially known as mushrooms [2]. Notwithstanding
the worldwide distribution of S. commune, it was ﬁrst identiﬁed as
a human pathogen when Kligman isolated it from a patient with
onychomycosis in 1950 [6]. Since then, it has been increasingly
reported as a cause of ABPM and other allergy-related broncho-
pulmonary and sinus diseases. Here, we describe ABPM that was
caused by A. fumigatus and S. commune co-infection. This condition
was diagnosed morphologically and genetically using a next-
generation sequencer.
Fig. 2. Aspergillus fumigatus and Schizophyllum commune isolated from mucus plug. (A) Morphologically characterized A. fumigatus. (B) Cultured S. commune isolate shows hyaline,
septate hyphae with clamp connections and spicules (400). (C) Granular to cottony, green-gray Aspergillus fumigatus colonies with apron at margin. (D) White, wooly colonies of
S. commune isolated from sputum and inoculated onto SGA supplemented with benomyl after 4 days of incubation at 28 8C. Slide (A and B) and SGA (C and D) cultures.
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of the bronchi (MIB) [7], the etiology is usually based on cultural
criteria. Molecular analyses have become more accurate for
identifying environmental fungi, but when unknown samples or
plural eumycetes are cultured from bronchial materials of MIB
patients, meticulous attention to detail is needed to diagnose
ABPM [3].
S. commune has been identiﬁed as an etiological agent of ABPM
as well as pulmonary fungal balls. This fungus is characterized by
clamp connections, hyphal spicules and the formation of
basidiocarps with basidiospores. Phenotypic identiﬁcation is
usually conﬁrmed by sequencing the ITS region. To date, ABPM
and pulmonary fungal balls due to S. commune have been found
predominantly in Japan and North America. Of the 71 globally
reported patients harboring S. commune, 45 (63%) had broncho-
pulmonary disease, 22 (31%) had sinusitis and four had extra-
pulmonary disease. The total number of bronchopulmonary
disease and sinusitis was 67 (94%), indicating that the respiratory
tract is the primary target of S. commune [2,4,5]. Chowdhary et al.
reported that ABPM in one of 19 patients from Japan was caused by
concomitant S. commune and A. fumigates colonization, as in our
patient [2,5].
Greer and Bolanos experimentally demonstrated the patho-
genic potential of S. commune in Swiss white mice using a
fragmented hyphal inoculum and an intraperitoneal route of
infection [8]. This fungus was more pathogenic to weaning mice
than to adults. In this model, cortisone or mucin or both rendered
the mice much more highly susceptible, causing a 75% fatality rate
with histological lesions in the lungs, lymph nodes, liver and
subcutaneous tissue.
We detected sequences that were more similar to those of S.
commune using a next-generation sequencer and conﬁrmed the
PCR-ampliﬁed genetic sequence. Our results suggest that these
tests are valuable when patients present with infections caused by
unknown fungi. Although high-throughput next-generation se-
quencing technologies might be difﬁcult to apply during routineclinical diagnosis, they have potential for clinical genomic studies,
as they can vastly exceed the data output of the most sophisticated
capillary sequencers based on the Sanger method [9].
With bacteremia, detection and conﬁrmation of pathogens can
be done quickly in patients using metagenomic sequencing can be
used along with blood cultures [10]. Speciﬁc fungal pathogens can
be directly detected and genetically analyzed similarly within 1
day, whereas routine fungal cultures may require weeks to detect
and identiﬁcation certain pathogens. A more rapid approach would
beneﬁt patients.
The role of antifungal therapy in ABPM and pulmonary fungal
balls due to S. commune remains unclear because of the rarity of
reports about these clinical entities and consequently limited
experience with their chemotherapeutic management. Chowdh-
ary et al. reported that oral and inhaled corticosteroids improved
symptoms in one patient with ABPM, whereas itraconazole
improved pulmonary fungal ball in a patient with diabetes [2]. In
vitro susceptibility tests of clinical S. commune isolates from both
of these patients revealed low MICs for amphotericin B,
caspofungin, micafungin, anidulafungin and all of the azoles.
Information about the antifungal sensitivity of S. commune in
vitro is, however, scarce. One study found that ﬁve test clinical
isolates of S. commune were susceptible to itraconazole,
voriconazole and amphotericin B [11]. Further studies of the
susceptibility of a large number of S. commune isolates to
antifungal agents in vitro are required to ensure appropriate and
effective antifungal therapy against these emerging pathogens,
and long-term follow-up is required to evaluate the therapeutic
value of antifungal agents.
In conclusion, we describe a patient who had been misdiag-
nosed with eosinophilic pneumonia and bronchial asthma but, in
fact, had ABPM due to co-infection with A. fumigatus and S.
commune. The pathogens were detected morphologically and by
genetic sequencing. Anti-fungal therapy improved the symptoms
and X-ray ﬁndings in this patient, but further study of the
pathogenesis of ABPM and S commune is needed.
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